Elsevier

Neuropharmacology

Volume 64, January 2013, Pages 314-320
Neuropharmacology

Nicotine improves performance in an attentional set shifting task in rats

https://doi.org/10.1016/j.neuropharm.2012.06.055Get rights and content

Abstract

A large number of studies in both humans and experimental animals have demonstrated nicotine-induced improvements in various aspects of cognitive function, including attention and memory. The prefrontal cortex (PFC) is thought to be critically involved in the modulation of executive function and these attentional processes are enhanced by nicotine acting at nicotinic acetylcholine receptors. The involvement of nicotinic processes on cognitive flexibility in particular has not been specifically investigated. The effects of nicotine on attentional flexibility were therefore evaluated using the rodent attentional set shifting task in rats. Nicotine injected both acutely and following repeated pre-exposure significantly improved both intradimensional and extradimensional set shifting performance in the task. Further investigation of the acute effects of nicotine demonstrated this improvement in attentional flexibility to be dose-dependent. These results implicate the nicotinic receptor system in the mediation of processes underlying cognitive flexibility and suggest that nicotine improves attentional flexibility in rats, both within and between perceptual dimensions of a compound stimulus. Nicotine-induced alterations in prefrontal circuitry may underlie these effects on cognitive flexibility.

This article is part of a Special Issue entitled ‘Cognitive Enhancers’.

Highlights

► Nicotine was observed to have procognitive effects using the attention shift task in rodents. ► The cognitive improvements on attentional flexibility were dependent on dose of nicotine. ► The improvements were persistent in rats treated sub-chronically with nicotine.

Introduction

Nicotine is widely accepted as the primary psychoactive agent in tobacco smoke and has been shown to improve cognitive performance across multiple domains (Levin et al., 2006). Interest in the development of nicotinic agonists as cognitive enhancers has gained momentum, since nicotinic receptors (nAChRs) have been implicated in neuropsychiatric diseases characterised by cognitive impairments including Alzheimer's, schizophrenia, attention-deficit hyperactive disorder and mild cognitive impairment (Newhouse et al., 2004, 2012).

Neuronal nAChRs are considered to be involved since they are widely distributed throughout the rat (Clarke et al., 1985; Tribollet et al., 2004) and human brain (Gotti et al., 1997). More specifically, there is evidence that the major nAChR subtypes in rats are highly expressed in brain regions subserving cognitive functions such as the prefrontal cortex (PFC) (Gil et al., 1997; Vidal and Changeux, 1993), a brain region known to play a critical role in the modulation of executive function (Dalley et al., 2004a; Chudasama and Robbins, 2006); the hippocampus and other subcortical limbic structures (Changeux et al., 1998; Gotti et al., 2006, 2007). Furthermore, in the PFC, dopamine and glutamate have been shown to be modulated by nicotine and subtype selective agonists (Livingstone et al., 2009) which further support the role for nAChRs in cognitive function (Vidal, 1996; Mansvelder et al., 2006).

In the preclinical literature, nicotine and other subtype nAChRs agonists have been demonstrated to improve sustained and divided aspects of attention (Stolerman et al., 2000; Hahn et al., 2002) using the five choice serial reaction time task (5CSRTT; developed by Carli et al., 1983). However, another important aspect of executive function based on prefrontal cortical function which has not been systematically studied with respect to nicotinic receptor involvement is attentional flexibility.

Attentional control involves the ability to change behaviour effectively in response to alterations in the significance of environmental stimuli, a process that requires flexibility of attentional set for different dimensional properties of stimuli. Attentional flexibility is commonly measured clinically using the Wisconsin Card Sorting Test (WCST; Milner, 1963). Birrell and Brown (2000) devised an analogous model to the Wisconsin Card Sorting Test (WCST) to be executed in rodents, the Attentional Set Shifting Task (ASST). The ASST is an adaptation of the WCST, utilising the dimensions of odour, medium and texture of the bowl (Birrell and Brown, 2000). The task requires the rodent to learn to associate a food reward with a specific dimension which is later changed during the task (extradimensional shift EDS). Birrell and Brown observed the rodents took more trials to complete the extradimensional shift (switching to a previously irrelevant stimulus, whilst ignoring the previously relevant stimulus) component of the task than the intradimensional shift (switching within the same relevant dimension) component when rodents had bilateral lesions of the prefrontal cortex (Birrell and Brown, 2000). Thus, the ASST assesses a rodent's ability to shift attention to allow investigation of the mechanisms underlying both attentional set formation and maintenance in addition to attentional flexibility and reversal learning. It is formally equivalent to the human and primate versions of the task (Brown and Bowman, 2002; Dias et al., 1996a, 1996b; Owen et al., 1991), but uses more species appropriate stimuli.

In view of nicotine's cognitive-enhancing effects on sustained attention in non-compromised rodents (Hahn et al., 2002), the present studies evaluated a similar dosing regimen of nicotine in the ASST. More specifically, given the relatively short half-life for metabolism of nicotine in rats, tests were applied just prior to the extra-dimensional shift. To gauge the specificity of any improvements, similar tests were conducted on the intra-dimensional shift. These studies would also provide the potential utility of assessing attentional flexibility as a domain sensitive to cognitive enhancement by psychoactive substances.

Section snippets

Materials and methods

Two separate studies were carried out to investigate the effects of nicotine in the attentional set shifting test in rats. The first was carried out with the aim of assessing whether the depressant effects of nicotine would prevent the rats from digging in the bowls and thus nicotine pretreatment for 5 days was employed as described for tests on 5 choice serial time task (Hahn et al., 2002). Furthermore, this level of nicotine exposure was also able to ascertain tolerance developed to the acute

Test 1: effects of nicotine on ED shift performance

Fig. 1A illustrates the number of trials to reach criterion performance of six consecutive correct digs on the series of discriminations performed during the first test session with injections carried out 10 min before commencement of the ED stage of the task. Two rats in the acute nicotine (VEH/NIC) group failed to complete the task, as they stopped responding after the ED stage. Data from these two animals was still included in the analysis as they had completed the ED discrimination. Four

Discussion

This study is the first to show that nicotine administered both acutely and sub-acutely in normal non-compromised rats improves performance in an attentional set shifting test when the animals are required to shift attentional set between stimuli both within (ID shift) and between (ED shift) perceptual stimulus dimensions. Furthermore, this observed nicotine-induced enhancement was demonstrated to be dose-dependent. These results further indicate that activation of neuronal nicotinic receptors

Acknowledgements

The authors thank Dr S. Bate for advice and assistance performing statistical analysis. This study was supported by the BBSRC grant BBS/B/15627 awarded to Dr M. Shoaib.

References (60)

  • M.D. Lapiz et al.

    Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability

    Neuroscience

    (2006)
  • J. McGaughy et al.

    Noradrenergic, but nor cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting

    Neuroscience

    (2008)
  • P.A. Newhouse et al.

    Effects of nicotinic stimulation on cognitive performance

    Curr. Opin. Pharmacol.

    (2004)
  • A.M. Owen et al.

    Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man

    Neuropsychologia

    (1991)
  • D.V. Poltavski et al.

    Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits

    Physiol. Behav.

    (2006)
  • M.E. Ragozzino et al.

    Involvement of the dorsomedial striatum in behavioural flexibility: role of muscarinic cholinergic receptors

    Brain Res.

    (2002)
  • S. Semenova et al.

    Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats

    Pharmacol. Biochem. Behav.

    (2007)
  • I.P. Stolerman et al.

    Nicotine in an animal model of attention

    Eur. J. Pharmacol.

    (2000)
  • D.S. Tait et al.

    Lesions of the basal forebrain impair reversal learning but not shifting of attentional set in rats

    Behav. Brain Res.

    (2008)
  • E. Tribollet et al.

    Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain

    Neuroscience

    (2004)
  • C. Vidal et al.

    Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro

    Neuroscience

    (1993)
  • G.L. Wenk

    The nucleus basalis magnocellularis cholinergic system: one hundred years of progress

    Neurobiol. Learn. Mem.

    (1997)
  • J.M. Birrell et al.

    Medial frontal cortex mediates perceptual attentional set shifting in the rat

    J. Neurosci.

    (2000)
  • A. Blondel et al.

    Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies

    Psychopharmacology (Berl.)

    (2000)
  • K.C. Chen et al.

    Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set-shifting

    Eur. J. Neurosci.

    (2004)
  • P.B. Clarke et al.

    Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin

    J. Neurosci.

    (1985)
  • J.W. Dalley et al.

    Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task

    J. Neurosci.

    (2001)
  • J.W. Dalley et al.

    Cortical cholinergic function and deficits in visual attentional performance in rats following 192 IgG-saporin-induced lesions of the medial prefrontal cortex

    Cereb. Cortex

    (2004)
  • E. Decamp et al.

    Effects of nicotinic therapies on attention and executive functions in chronic low-dose MPTP-treated monkeys

    Eur. J. Neurosci.

    (2006)
  • R. Dias et al.

    Dissociation in prefrontal cortex of affective and attentional shifts

    Nature

    (1996)
  • Cited by (48)

    • Nicotine's effect on cognition, a friend or foe?

      2022, Progress in Neuro-Psychopharmacology and Biological Psychiatry
    • Adolescent binge ethanol exposure alters specific forebrain cholinergic cell populations and leads to selective functional deficits in the prefrontal cortex

      2017, Neuroscience
      Citation Excerpt :

      However, the role of ACh in set shifting is complex: Whereas NbM cholinergic lesions do not impair set shifting (McGaughy et al., 2008; Tait and Brown, 2008), modulation of nicotinic acetylcholine receptors enhances set shifting (Allison and Shoaib, 2013; Nikiforuk et al., 2015), and muscarinic receptor antagonism impairs set shifting (Soffie and Lamberty, 1987; Chen et al., 2004). Although the evidence from lesion studies suggest that ACh modulation of set-shifting behavior is extra-cortical (Allison and Shoaib, 2013), it likely that ACh interactions with multiple neurotransmitters across multiple cholinergic sites contribute to successful/unsuccessful cognitive flexibility (Prado et al., 2017). The AIE model does lead to loss of cholinergic neurons across the basal forebrain and brainstem projection systems, as well as a reduction in striatal cholinergic interneurons (Vetreno et al., 2014).

    View all citing articles on Scopus
    View full text